Pembrolizumab Approved for Relapsed/Refractory Adult and Pediatric Hodgkin Lymphoma
March 15th 2017Pembrolizumab (Keytruda) received an accelerated approval for adult and pediatric patients with refractory classical Hodgkin lymphoma or those who have relapsed after at least 3 lines of therapy.
Read More
Study Compares Cost-Effectiveness of Immune Checkpoint Inhibitors in Advanced Melanoma
March 7th 2017First-line pembrolizumab every 3 weeks followed by second-line ipilimumab, and first-line nivolumab followed by second-line ipilimumab are cost-effective strategies in patients with advanced melanoma expressing wild-type BRAF.
Read More
Pediatric Patients With Irritable Bowel Syndrome Have Vitamin D Deficiency
March 1st 2017A vitamin D deficit may be linked with irritable bowel syndrome (IBS) in children. According to a new study published in PLOS ONE, more than 90% of pediatric patients with IBS were deficient in vitamin D.
Read More
Raising Awareness of Rare Diseases and the Need for More Research
February 28th 2017The National Organization for Rare Disorders has announced a new, yearlong campaign to raise public awareness of rare diseases. “Do Your Share for Rare” shines a light on people living with a rare disease and provides an opportunity for them to share their story.
Read More